We connect the best Research Sites with Sponsors and CROs to reduce drug development costs and cure disease.
Devana Solutions®, LLC is a SaaS provider driven by a core belief that data transparency through technology is critical to selection of the top performing research sites to align with pharmaceutical sponsors and cros to reduce drug development costs and cure disease. Devana Solutions® offers three platforms, IGNITE for sites, PROPEL for networks and IQ for Sponsors and CROs, to provide historical and real-time data capture, aggregation and display to drug development stakeholders.
Devana Solutions® is the leading cloud-based provider of technology that helps save time through automating clinical trial workflows at the site-level from initial study lead to completion. At the same time, the Devana platform allows for the capture, aggregation and display of site performance metrics for analysis by key stakeholders from site or site network to Sponsors and CROs.
At Devana Solutions®, our unwavering commitment of data transparency through technology inspires the cloud-based technology platforms we build, license and support.
IGNITE for sites arms investigators, research sites and site networks with time-saving automation and powerful data to reduce study start-up, improve operations and win more study awards in less time. Use the technology to prove your therapeutic strengths, enrollment capabilities and operational-expertise by easily reporting and displaying timing and performance metrics to Sponsors and CROs.
Gain total transparency into your site or site network’s historic and real-time performance – both good and bad – and use these analytics to help your management team improve study operations and performance and therapeutically and operationally align with the right Sponsors and CROs.
Save valuable time for your site managers by centralizing and automating your contacts, pipeline and document administration to track study leads and capture critical timing and performance metrics datapoints all the way through trial completion and close out.
Drug Sponsors and CROs must find and select the best research sites – those that consistently recruit, screen and enroll more patients, faster and safely while gathering clean, accurate data on a drug’s safety and effectiveness – to REDUCE CLINICAL TRIAL CYCLE TIME and drug development costs.
IQ for sponsors-cros reduces site selection risk for Sponsors and CROs by providing full transparency into an investigative site or site network’s historic and real-time performance and timing metrics data, improving trial feasibility and performance while reducing clinical trial cycle time and costs.